H. Ishizaki
About
In The Last Decade
H. Ishizaki
16 papers receiving 487 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 255
- Pharmacology 138
- Plant Science 119
- Oncology 79
- Biochemistry 51
Countries citing papers authored by H. Ishizaki
This map shows the geographic impact of H. Ishizaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ishizaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ishizaki more than expected).
Fields of papers citing papers by H. Ishizaki
This network shows the impact of papers produced by H. Ishizaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ishizaki. The network helps show where H. Ishizaki may publish in the future.
Co-authorship network of co-authors of H. Ishizaki
This figure shows the co-authorship network connecting the top 25 collaborators of H. Ishizaki. A scholar is included among the top collaborators of H. Ishizaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Ishizaki. H. Ishizaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 36 | |
| 3 | 68 | |
| 4 | In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites. | 6 |
| 5 | In vitro metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo+ ++[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), in mice, rats, dogs, and humans. | 6 |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | Enzyme mechanisms in the metabolism of nitrosamines. | 23 |
| 10 | Enzyme kinetics of N-nitrosodimethylamine demethylase in rodents and humans. | 3 |
| 11 | 66 | |
| 12 | Formation of hydroxy derivatives, aldehydes, and nitrite from N-nitrosomethyl-n-amylamine by rat liver microsomes and by purified cytochrome P-450 IIB1. | 15 |
| 13 | 48 | |
| 14 | Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. | 152 |
| 15 | 10 | |
| 16 | 37 | |
| 17 | 26 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.